Novel targets in the treatment of chronic graft-versus-host disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel targets in the treatment of chronic graft-versus-host disease
Authors
Keywords
-
Journal
LEUKEMIA
Volume 31, Issue 3, Pages 543-554
Publisher
Springer Nature
Online
2016-11-30
DOI
10.1038/leu.2016.367
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice
- (2016) H. Jin et al. BLOOD
- Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?
- (2016) R. Zeiser et al. BLOOD
- Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism
- (2016) R. Flynn et al. BLOOD
- Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease
- (2016) John Koreth et al. BLOOD
- Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease
- (2016) Isabel Sánchez-Ortega et al. CROATIAN MEDICAL JOURNAL
- Thymus: the next (re)generation
- (2016) Mohammed S. Chaudhry et al. IMMUNOLOGICAL REVIEWS
- Phase II Multicenter, Randomized, Double-Blind Controlled Study of Efficacy and Safety of Umbilical Cord–Derived Mesenchymal Stromal Cells in the Prophylaxis of Chronic Graft-Versus-Host Disease After HLA-Haploidentical Stem-Cell Transplantation
- (2016) Lei Gao et al. JOURNAL OF CLINICAL ONCOLOGY
- Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease
- (2016) Frances T. Hakim et al. JOURNAL OF IMMUNOLOGY
- Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Philippe Moreau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ponesimod, a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases
- (2016) Daniele D’Ambrosio et al. Therapeutic Advances in Chronic Disease
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report
- (2015) Paul J. Martin et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial
- (2015) John Koreth et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report
- (2015) Sophie Paczesny et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Ofatumumab in Combination with Glucocorticoids for Primary Therapy of Chronic Graft-versus-Host Disease: Phase I Trial Results
- (2015) Joseph Pidala et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- B Cells in Chronic Graft-versus-Host Disease
- (2015) Stefanie Sarantopoulos et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
- (2015) Sally Arai et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
- (2015) Stephanie J. Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
- (2015) Madan H. Jagasia et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease
- (2015) R. Flynn et al. BLOOD
- Aberrant B-cell homeostasis in chronic GVHD
- (2015) S. Sarantopoulos et al. BLOOD
- The novel mechanism of lenalidomide activity
- (2015) E. C. Fink et al. BLOOD
- Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
- (2015) C. G. Brunstein et al. BLOOD
- Childhood to adult transition and long-term follow-up after blood and marrow transplantation
- (2015) M C Cupit et al. BONE MARROW TRANSPLANTATION
- Pharmacologic Inhibition of JAK1/JAK2 Signaling Reduces Experimental Murine Acute GVHD While Preserving GVT Effects
- (2015) C. Carniti et al. CLINICAL CANCER RESEARCH
- A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation
- (2015) S. Arai et al. CLINICAL CANCER RESEARCH
- Outcomes of acute leukemia patients transplanted with naive T cell–depleted stem cell grafts
- (2015) Marie Bleakley et al. JOURNAL OF CLINICAL INVESTIGATION
- Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
- (2015) R Zeiser et al. LEUKEMIA
- Modern approaches to HLA-haploidentical blood or marrow transplantation
- (2015) Christopher G. Kanakry et al. Nature Reviews Clinical Oncology
- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
- (2015) A. Keith Stewart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice
- (2015) Steven D. Schutt et al. PLoS One
- A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft-versus-Host Disease
- (2014) Alex F. Herrera et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Treatment of chronic graft-versus-host disease with bortezomib
- (2014) C.-C. S. Pai et al. BLOOD
- Increased BCR responsiveness in B cells from patients with chronic GVHD
- (2014) Jessica L. Allen et al. BLOOD
- Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
- (2014) S. Spoerl et al. BLOOD
- Current issues in chronic graft-versus-host disease
- (2014) G. Socie et al. BLOOD
- Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
- (2014) Jason A. Dubovsky et al. JOURNAL OF CLINICAL INVESTIGATION
- Blockade of Syk ameliorates the development of murine sclerodermatous chronic graft-versus-host disease
- (2014) Doanh Le Huu et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial
- (2014) T. Olsson et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect
- (2014) Jaebok Choi et al. PLoS One
- Bronchoalveolar Lavage as a Tool to Predict, Diagnose and Understand Bronchiolitis Obliterans Syndrome
- (2013) V. E. Kennedy et al. AMERICAN JOURNAL OF TRANSPLANTATION
- FTY720 Ameliorates Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Promoting Expansion of Splenic Regulatory Cells and Inhibiting Immune Cell Infiltration Into Skin
- (2013) Doanh Le Huu et al. ARTHRITIS AND RHEUMATISM
- National Institutes of Health Chronic Graft-versus-Host Disease Staging in Severely Affected Patients: Organ and Global Scoring Correlate with Established Indicators of Disease Severity and Prognosis
- (2013) Kristin Baird et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- In Vivo T Cell Costimulation Blockade with Abatacept for Acute Graft-versus-Host Disease Prevention: A First-in-Disease Trial
- (2013) Divya T. Koura et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo
- (2013) A. Heine et al. BLOOD
- Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial
- (2013) C. Cutler et al. BLOOD
- JAKs and STATs in Immunity, Immunodeficiency, and Cancer
- (2013) John J. O'Shea et al. NEW ENGLAND JOURNAL OF MEDICINE
- H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease
- (2013) B. Sahaf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis
- (2013) Robert Stockley et al. RESPIRATORY MEDICINE
- Combined Inhibition of c-Abl and PDGF Receptors for Prevention and Treatment of Murine Sclerodermatous Chronic Graft-versus-Host Disease
- (2012) Pawel Zerr et al. AMERICAN JOURNAL OF PATHOLOGY
- Inhibition of hedgehog signalling prevents experimental fibrosis and induces regression of established fibrosis
- (2012) Angelika Horn et al. ANNALS OF THE RHEUMATIC DISEASES
- Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
- (2012) S. Arai et al. BLOOD
- Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease
- (2012) P. Zerr et al. BLOOD
- IFN R signaling mediates alloreactive T-cell trafficking and GVHD
- (2012) J. Choi et al. BLOOD
- Efficacy, safety and effect on biomarkers of AZD9668 in cystic fibrosis
- (2012) J. Stuart Elborn et al. EUROPEAN RESPIRATORY JOURNAL
- Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation
- (2012) John Koreth et al. JOURNAL OF CLINICAL ONCOLOGY
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
- (2012) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans
- (2011) M. Srinivasan et al. BLOOD
- Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium
- (2011) J. Pidala et al. BLOOD
- Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria
- (2011) S. Arai et al. BLOOD
- Rituximab for prevention and treatment of graft-versus-host disease
- (2011) Mohamed A. Kharfan-Dabaja et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation
- (2011) John R. Wingard et al. JOURNAL OF CLINICAL ONCOLOGY
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD
- (2011) Piotr Kuna et al. RESPIRATORY MEDICINE
- Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease
- (2010) Daniel Wolff et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
- (2010) J Y Weng et al. BONE MARROW TRANSPLANTATION
- Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation
- (2010) I. Tawara et al. CLINICAL CANCER RESEARCH
- Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation
- (2010) Paul J. Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- The S1P1-mTOR axis directs the reciprocal differentiation of TH1 and Treg cells
- (2010) Guangwei Liu et al. NATURE IMMUNOLOGY
- Sphingosine-1-phosphate and immune regulation: trafficking and beyond
- (2010) Hongbo Chi TRENDS IN PHARMACOLOGICAL SCIENCES
- Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation—An Increasingly Recognized Manifestation of Chronic Graft-versus-Host Disease
- (2009) Jason W. Chien et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The role of B cells in the pathogenesis of graft-versus-host disease
- (2009) A. Shimabukuro-Vornhagen et al. BLOOD
- Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
- (2009) S. Sarantopoulos et al. BLOOD
- Janus kinases in immune cell signaling
- (2009) Kamran Ghoreschi et al. IMMUNOLOGICAL REVIEWS
- Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus
- (2009) Agnès Doreau et al. NATURE IMMUNOLOGY
- Bortezomib Can Suppress Activation of Rapamycin-Resistant Memory T Cells Without Affecting Regulatory T-Cell Viability in Non-Human Primates
- (2009) Jung-Sik Kim et al. TRANSPLANTATION
- Murine Models of Chronic Graft-versus-Host Disease: Insights and Unresolved Issues
- (2008) Yu-Waye Chu et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started